Novartis’s next generation Technology Platforms strategy was outlined to investors by our CEO, Vas Narasimhan.

Our new strategy provides a focus on five technology platforms – highlighting an increasing shift towards biologics and advanced technology platforms. We will shift towards both biologics and advanced technology platforms and build leadership across three next-generation technology platforms: xRNA, Radioligand, and Gene and Cell Therapy.

0:00
0:14 Advanced technology platforms
0:33 Gene therapy
0:53 Cell therapy
1:25 Radioligand therapy

JP Morgan Healthcare Conference
Event Date: January 9, 2023
Investors Events: [ Ссылка ]
Novartis Strategy: [ Ссылка ]

Disclaimer: JP Morgan healthcare conference contains forward-looking statements. Such forward-looking statements are subject to significant known and unknown risks and uncertainties. Visit our website for more information: [ Ссылка ]

Follow @Novartis on Twitter: [ Ссылка ]
Follow Novartis on LinkedIn: [ Ссылка ]

свернуть